CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients
Authors
A Lucia
A Renand
+57 more
A Wroblewska
AC Nascimbeni
AF Santos
AH El-Gharbawy
AT Palermo
AT van der Ploeg
AT van der Ploeg
AT van der Ploeg
AWGoMoP Disease
B Knoechel
B Sun
CA Akdis
D Orlikowski
DP Germain
E Martinuzzi
EM Moran
F Dazzi
F Meiler
F Mingozzi
G Hu
G Shankar
GE Linthorst
GM Bartelds
H Galjaard
J Oldenburg
JM de Vries
JR Mendell
JS Park
JW Teener
KM Flanigan
M Banati
M Keiserman
M Kroos
M Nicolino
MJ Allen
NJ Mendelsohn
NJ Singh
P Dickson
PA Blair
PC Moorehead
PS Kishnani
PS Kishnani
R Kakavanos
RC Aalberse
S Nayak
S Nayak
SA Montalvao
SE Lipinski
SF Whelan
SG Banugaria
SG Banugaria
SN Prater
SO Han
SS Fakharzadeh
TT Patel
W van de Veen
YH Messinger
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1038%2Fsrep36182
Last time updated on 04/12/2019